Patients were randomized into two groups : group @ included patients who received rosuvastatin therapy in an average dose of @ mg/day ( n = @ ) ; group @ included patients who received combination treatment with atorvastatin in an average dose of @ mg/day and ezetimibe ( @ mg ) ( n = @ ) .